New research suggests that weight loss drugs like Saxena and Trulicity may help reduce the risk of obesity-related cancers, which are linked to 13 types of cancer. A study compared patients who underwent bariatric surgery with those taking GLP-1 receptor agonists, finding that the drugs could be 41% more effective at preventing these cancers. However, the study has limitations, including a small number of diagnosed cases and the need for larger trials to confirm these findings.